ms and glp 1 GLP-1 Agonists: Weight Loss Shots The Interplay Between GLP-1-Based Therapies,

Moslehi, J., Lichtman, A

Of the 3,791 studies we investigated, 715 were active 2 and 69% of those involved either Diabetes or Obesity

Tesamorelin for Visceral Fat Tesamorelin is a growth hormone releasing hormone (GHRH) analog FDA-approved for HIV-associated lipodystrophy

The trial enrolled 76 adults with type 2 diabetes and randomized them to placebo, a three-strain formula or the five-strain formula now sold as Glucose Control After 12 weeks, the group taking the five-strain probiotic saw a statistically significant improvement in post-meal blood sugar spikes and total glucose response after a test meal compared with the placebo group